VT-BEST Event: Science Policy Mini-Internship

Science Policy Mini-Internship

Workshop Leaders:
Dr. Meredith Fox: Director of Office of Science Policy, Planning, and Communications at NIMH. Dr. Fox will provide a perspective from the public sector.
Dr. Gregory Frank: Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO). Dr. Frank will provide a perspective from the private sector.

April 13th, 2018; Time: 8:30am-Noon, Virginia Tech Carilion Research Institute, 2 Riverside Circle, Roanoke, VA

Gregory Frank and Meredith Fox will offer a fun Science Policy Mini-internship workshop to provide trainees with hands-on exercises and case studies in consensus building and communicating policy positions. The goal is to better understand the function of the policy analyst and skills required to be successful at the job.
Location: Roanoke Campus. Room number provided with registration confirmation.
REGISTRATION REQUIRED, Limited to 21 PhD students and postdocs.

Register Here

Please consider attending!

SPEAKER BIO’S:
Dr. Greg Frank
Greg Frank has a research background in immunology, where he trained at the University of Pittsburgh studying viral infection of the eye. In 2010 he went on to pursue his postdoctoral training at the National Institutes of Allergy & Infectious Diseases (NIAID) Laboratory of Viral Diseases (LVD), researching the immune response to influenza infection.
Greg transitioned into science policy through a 2013 fellowship with the Federation of American Societies for Experimental Biology (FASEB), where he helped develop a best practice document on mitigating the risk to animal rights extremism. In 2014 Greg then joined the Infectious Diseases Society of America (IDSA) to lead science and diagnostic policy. At IDSA he worked on issues that included infectious disease physician scientist workforce issues, dual use research of concern, and policies to drive the development and clinical integration of rapid infectious disease diagnostics.
In 2016, Greg joined the Biotechnology Innovation Organization (BIO), where he leads several infectious diseases policy issues, including antimicrobial resistance and vaccine policy.

Dr. Meredith Fox
Dr. Meredith Fox received her Ph.D. in Behavioral Neuroscience/Psychology from American University, where she studied the rewarding and aversive motivational effects of drugs of abuse. Following her Ph.D., she was appointed as an Assistant Professor in the Department of Psychology at American University, where she directed a small research team investigating behavioral pharmacology. Dr. Fox then worked in the National Institute of Mental Health (NIMH) Intramural Research Program (IRP) in the Laboratory of Clinical Science for nearly eight years, first as a Postdoctoral Fellow and later as a Senior Research Fellow, serving as the Deputy Laboratory Chief during her last two years. Her research focused on serotonin and its transporter, SERT. In 2012, Dr. Fox went on Detail in the NIMH Extramural Office of Science Policy, Planning, and Communications (OSPPC), and soon after joined the Science Policy and Evaluation (SPE) Branch in OSPPC as a Health Science Policy Analyst, and later as the Chief of the SPE Branch. Dr. Fox currently serves as the Director of OSPPC.